Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER‐1 study
Kazuomi Kario, Koichiro Yamasaki, Kazuro Yagi, et al.
Journal of Clinical Hypertension (2019) Vol. 21, Iss. 7, pp. 896-903
Open Access | Times Cited: 16

Showing 16 citing articles:

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Hypertension facilitates age-related diseases. ~ Is hypertension associated with a wide variety of diseases?~
Masaki Mogi, Yasuhito Ikegawa, Shunsuke Haga, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1246-1259
Open Access | Times Cited: 7
A review of symptom, pathogenesis and treatment characteristics of the elderly with chronic insomnia
LiBo Xia, Haiyan Liu, Jixiang Ren
Medicine (2025) Vol. 104, Iss. 5, pp. e41346-e41346
Open Access
Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Early life stress and hormonal status influence orexin‐1 receptor expression in structures regulating cardiorespiratory responses to CO2
Stéphanie Fournier, Julie Plamondon, Denis Richard, et al.
Experimental Physiology (2025)
Open Access
Type 5 phosphodiesterase (PDE5) and the vascular tree: From embryogenesis to aging and disease
Valeriana Cesarini, Eugenia Guida, Federica Campolo, et al.
Mechanisms of Ageing and Development (2020) Vol. 190, pp. 111311-111311
Open Access | Times Cited: 22
Treating sleep disorders to improve blood pressure control and cardiovascular prevention: a dream come true?—a narrative review
Giuseppe Maiolino, Valeria Bisogni, Alessandro Silvani, et al.
Journal of Thoracic Disease (2020) Vol. 12, Iss. S2, pp. S225-S234
Open Access | Times Cited: 16
Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function
Jeremy A. Bigalke, Zhiying Shan, Jason R. Carter
Hypertension (2022) Vol. 79, Iss. 12, pp. 2643-2655
Open Access | Times Cited: 10
Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
Kazuomi Kario
Korean Circulation Journal (2019) Vol. 49, Iss. 12, pp. 1123-1123
Open Access | Times Cited: 13
Insomnia and hypertension: A misty landscape
Konstantinos Stavropoulos, Κonstantinos Imprialos, Michael Doumas, et al.
Journal of Clinical Hypertension (2019) Vol. 21, Iss. 6, pp. 835-837
Open Access | Times Cited: 4
Clinical studies on pharmacological treatment of hypertension in Japan
Kazuomi Kario, Satoshi Hoshide, Kōichi Yamamoto, et al.
Journal of Human Hypertension (2021) Vol. 38, Iss. 6, pp. 486-499
Closed Access | Times Cited: 3
Safety of Orexin Receptor Antagonist on Cardiac and Respiratory Function in Patients who Underwent Off-pump Coronary Artery Bypass Grafting
Kiyoshi Tamura, Toshiyuki Maruyama, Shogo Sakurai
Journal of Coronary Artery Disease (2021) Vol. 27, Iss. 2, pp. 53-57
Open Access | Times Cited: 2
Page 1

Scroll to top